2,3-Dihydro-3-[4-(substituted)-1-piperazinyl]-1H-isoindol-1-ones

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544360, 544373, 544295, 544357, 26032611R, 424251, 544364, C07D40304, C07D40314, A61K 3141

Patent

active

043550312

ABSTRACT:
Pyrazinoisoindolone derivatives of the formula ##STR1## wherein R.sup.1 is lower alkyl, phenyl, diphenylmethyl, pyridinyl, pyrimidinyl, pyrazinyl or pyrazinyl substituted with a lower alkyl, lower alkoxy or halo; and R.sup.2 is hydrogen, lower alkyl or di(lower)alkylamino(lower)alkyl are useful as antihypertensive agents.

REFERENCES:
patent: 3579524 (1971-05-01), Van Dyke et al.
Graf, W., et al., Helv. Chem. Acta, 42, pp. 1085-1101, 1959.
Topliss, J. G. et al., J. Med. Chem., 7, pp. 453-456, 1964.
P. Truitt et al., J. Med. Chem., 8,731 (1965).
H.-J. W. Vollmann et al., Chem. Berg., 105, 2933 (1972), see also Chem. Abstr., 77,151795d (1972), attached hereto.
R. R. Schmidt and E. Schlipp, Chem. Ber., 103, 3783 (1970), see also Chem. Abstr., 103, 3783 (1970), attached hereto.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,3-Dihydro-3-[4-(substituted)-1-piperazinyl]-1H-isoindol-1-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,3-Dihydro-3-[4-(substituted)-1-piperazinyl]-1H-isoindol-1-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-Dihydro-3-[4-(substituted)-1-piperazinyl]-1H-isoindol-1-ones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1338508

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.